Antidote Technologies
PrivateLast Round
Series C
Jun 3, 2021
Total Funding Raised
$41M
Company Overview
Antidote Technologies operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a Series C round in June 2021.
Antidote Technologies is a digital health company that provides a patient recruitment and matching platform to connect individuals with clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antidote Technologies Comparables
Compare Antidote Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Patiro | 86% | |
| AutoCruitment | 86% | |
| Carebox Healthcare Solutions | 86% |
For institutional investors. Book with your work email.
Antidote Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 3, 2021 | ||||
| VC Round | Sep 7, 2017 | ||||
| Series B | Feb 5, 2015 | ||||
| Series A | May 8, 2013 | ||||
| Seed | Oct 27, 2011 |
For institutional investors. Book with your work email.
Antidote Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Series B, Series A, Seed |
| Smedvig Capital | Series C, VC Round, Series B |
| LBO France | Series C |
| Octopus Investments | Series B, Series A |
| Octopus Ventures | Series C, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2017
$11M round led by Merck & Co., Inc.
- Feb 5, 2015
$14M round led by Smedvig Capital.
For institutional investors. Book with your work email.
Antidote Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Antidote Technologies's valuation, stock price, and market status.
Is Antidote Technologies a public or private company?
Antidote Technologies is a private company.
What is the current stock price of Antidote Technologies?
Antidote Technologies is a private company, so its shares have no public market price. Caplight tracks Antidote Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Antidote Technologies worth (valuation)?
Valuation information for Antidote Technologies is not publicly available.
Can I buy Antidote Technologies stock?
Antidote Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Antidote Technologies's last funding round?
Antidote Technologies's most recent funding round was Series C on June 3, 2021.
Who are the main investors in Antidote Technologies?
Key investors in Antidote Technologies include Amadeus Capital Partners, Smedvig Capital, LBO France, Octopus Investments.
Will Antidote Technologies IPO soon?
No public IPO plans have been announced for Antidote Technologies.
How can I track Antidote Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Antidote Technologies's shares on secondary markets.